Black Diamond Therapeutics Inc (BDTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	70.00	-	-
Operating Expenses	18.20% 10.98	13.42	15.47	18.27	18.13
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	18.20% 10.98	13.42	15.47	-	-
Operating Income/Loss	18.20% -10.98	-13.42	54.53	-18.27	-18.13
Nonoperating Income/Loss	13.26% 2.48	2.859	2.012	2.29	2.573
Income/Loss From Continuing Operations Before Tax	19.53% -8.498	-10.56	56.54	-15.98	-15.56
Income/Loss From Continuing Operations After Tax	19.53% -8.498	-10.56	56.54	-15.98	-15.56
Net Income/Loss	19.53% -8.498	-10.56	56.54	-15.98	-15.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.22% 56.93	56.80	56.66	0.5303	56.51
Diluted Average Shares	0.22% 56.93	56.80	57.67	0.5303	56.51
Basic Earnings Per Share	21.05% -0.15	-0.19	1.00	-0.28	-0.28
Diluted Earnings Per Share	21.05% -0.15	-0.19	0.98	-0.28	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-